Sox re-activation in response to bevacizumab growth factor inhibition.

Sox factors mediate entry into the transformed state. We describe here re-activation of nuclear factors from the Sox homeobox family in response to clinical interventions involving inhibition of the VEGF-A growth factor signaling pathway by bevacizumab (Avastin).

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-31
DOI
https://doi.org/10.5281/zenodo.23837266
Primary Topic
Angiogenesis and VEGF in Cancer
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Sox re-activation in response to bevacizumab growth factor inhibition.

Shahan Mamoor
Zenodo (CERN European Organization for Nuclear Research)
Angiogenesis and VEGF in Cancer
preprint

Sox re-activation in response to bevacizumab growth factor inhibition.

Shahan Mamoor
preprint en

Abstract

Sox factors mediate entry into the transformed state. We describe here re-activation of nuclear factors from the Sox homeobox family in response to clinical interventions involving inhibition of the VEGF-A growth factor signaling pathway by bevacizumab (Avastin).

Zenodo (CERN European Organization for Nuclear Research)
Angiogenesis and VEGF in Cancer
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Sox re-activation in response to bevacizumab growth factor inhibition. — Shahan Mamoor · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS